BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cytiva Introduces MabSelect SuRe 70 & PrismA X to Boost Cost-Efficient mAb Purification

MabSelect SuRe 70 and MabSelect PrismA X resins to set new standards in affordability and productivity Cytiva's expanded resin portfolio wil...

April 04, 2025 | News

IRBM Launches Advanced Functional Genomics Platform to Power Precision Target Discovery and Validation

IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a comprehensive Functional Genomics Pl...

April 03, 2025 | News

SHL Medical Launches $220M Autoinjector Facility in South Carolina to Boost US Production and Global Supply

SHL Medical, a global leader in the design, development, and manufacturing of advanced self-injection solutions, has officially inaugurated its new state-o...

April 02, 2025 | News

Henlius and Organon’s HLX11 Biosimilar of Pertuzumab Accepted for Review by European Medicines Agency

Shanghai Henlius Biotech, Inc. and Organon announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Appli...

March 31, 2025 | News

KELES and PwC Set Benchmark with First SFDR Article 9 ESG Framework for Digital Health VC

PwC and KELES, the pioneering digital health venture capital (VC) firm, are setting a new standard in digital health investment, leveraging ESG and innovat...

March 28, 2025 | News

Vaximm Reports Promising Final Data from Phase 2a Trial of Oral Vaccine VXM01 with Avelumab in Recurrent Glioblastoma

Vaximm AG, a subsidiary of OSR Holdings, Inc. and a pioneering biotechnology company focused on developing innovative immunotherapies, announced fina...

March 27, 2025 | News

Thermo Fisher Scientific Launches IVDR-Compliant SeqStudio™ Flex Dx to Elevate Clinical Lab Performance

— Thermo Fisher Scientific, the world leader in serving science, has announced the launch of the Applied Biosystems™ SeqStudio™ Flex Dx G...

March 26, 2025 | News

CStone Submits EMA Application to Expand Sugemalimab Use in Stage III Lung Cancer

CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, announced the submiss...

March 25, 2025 | News

Menarini Group, Stemline, and VisualDx Join Forces to Boost Early Detection of BPDCN Using AI-Driven Skin Imaging

BPDCN is an aggressive hematologic malignancy with a historically poor prognosis VisualDx is a clinical decision support system used by more than 2,300 ...

March 21, 2025 | News

Advanced Instruments to Acquire Nova Biomedical, Creating a Global Life Science Tools Powerhouse

Patricia Industries' subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, announ...

March 20, 2025 | News

Celonic Integrates Merck’s Breez™ Micro-Bioreactor to Advance mAb Development

Celonic Group, a Swiss-Based Quality contract development and manufacturing organization (CDMO), has announced that it is integrating Merck’s Breez&t...

March 13, 2025 | News

Pierre Fabre and RedRidge Bio Partner to Develop Biparatopic Antibody Drug Candidates

Pierre Fabre Laboratories and RedRidge Bio announced an exclusive R&D collaboration and license agreement to identify and develop biparatopic...

March 13, 2025 | News

Qureight and Remedy Cell Partner to Validate RC-0315’s Regenerative Potential in Idiopathic Pulmonary Fibrosis

Qureight Ltd, a Core Imaging Laboratory with deep-learning analytics, and Remedy Cell, a clinical-stage biopharmaceutical company focused on the developmen...

March 12, 2025 | News

Vetter to Double Cool Storage Capacity by 2028 with €150M Investment

Cool storage volume to be doubled by 2028 Third expansion stage of Vetter’s Center for Visual Inspection and Logistics State-of-the art, fully au...

March 11, 2025 | News

Stay Connected